MARINA FORTE: Open Payments
NPI 1356013049 · SONOMA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$829 in 33 payments from 13 companies in 2025. Trend: 2023 $368 · 2024 $675 · 2025 $829
Food & beverage: $730Education: $99
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $164 |
| Lilly USA, LLC | 2 | $93 |
| ABBVIE INC. | 4 | $81 |
| Novartis Pharmaceuticals Corporation | 3 | $80 |
| Incyte Corporation | 3 | $73 |
| Janssen Biotech, Inc. | 3 | $66 |
| LEO Pharma Inc. | 2 | $56 |
| Regeneron Healthcare Solutions, Inc. | 2 | $54 |
| GENZYME CORPORATION | 2 | $46 |
| Galderma Laboratories, L.P. | 2 | $43 |
Products named: DUPIXENT, EBGLYSS, OPZELURA, TREMFYA, SKYRIZI, Rhapsido, ADBRY, ILUMYA.
Industry payments across CA — which companies pay providers there.
